Researchers at Hudson Institute of Medical Research discovered a novel RUNX1 genetic variant linked to unexplained severe osteoporosis in young adults. The study's findings suggest that this mutation may be responsible for the condition's severity and potentially lead to targeted treatment options.
A diverse gut microbiome is linked to better health, and a new study reveals how to determine which species are important and interact to create a healthy balance. The findings have significant implications for conditions like Inflammatory Bowel Disease, infections, autoimmune diseases, and cancers.
A cancer drug, idronoxil, has been shown to reduce inflammation caused by COVID-19, according to research published in Nature Communications. The study found that idronoxil can target specific inflammatory pathways, limiting the damage without increasing viral replication.